论文部分内容阅读
目的析联合雾化吸入对老年喘息型慢性支气管炎的疗效。方法择取我院从2013年5月开始,到2015年4月为止,接收的老年喘息型慢性支气管炎患者,共78例。按照随机分组原理,将78例患者分成实验组与对照组,各39例。两组都行基础治疗,实验组同时辅以联合雾化吸入治疗;而对照组,则选取盐酸氨溴索药物,进行雾化吸入。观察两组疗效,并行对比分析。结果实验组痊愈及好转者,共37例,所占百分比为94.87%;对照组痊愈及好转者,共30例,所占百分比为76.92%。实验组总有效率94.87%,明显高于对照组76.92%。两组对比,差异具有统计学意义(P<0.05)。结论于老年喘息型慢性支气管炎的基础治疗中,加用联合雾化吸入疗法,可取得较理想的应用成效,值得临床借鉴。
Objective To analyze the efficacy of inhalation combined with inhalation on asthmatic chronic bronchitis in the elderly. Methods Select our hospital from May 2013 to April 2015, receiving elderly patients with wheezing chronic bronchitis, a total of 78 cases. In accordance with the principle of random grouping, 78 patients were divided into experimental group and control group, 39 cases each. The two groups were treated with basic treatment, while the experimental group supplemented by combined inhalation therapy; while the control group, the ambroxol hydrochloride drug was selected for nebulization. The curative effect of two groups were observed and analyzed in parallel. Results The experimental group cured and improved, a total of 37 cases, the percentage of 94.87%; control group recovered and improved, a total of 30 cases, the percentage was 76.92%. The total effective rate was 94.87% in the experimental group, which was significantly higher than 76.92% in the control group. The difference between the two groups was statistically significant (P <0.05). Conclusion In the basic treatment of chronic asthmatic chronic bronchitis, combined with the combination of inhalation therapy, can achieve more satisfactory results, it is worth learning from.